Niclas Adler
President chez Indonesia International Institute For Life Sciences
Profil
Niclas Adler is currently the Chairman of Akinion Pharmaceuticals AB, e-Cognition Pte Ltd., PT Accelerated Value, Accelerated Drug Development AB, SCI Innovation AB, Ao Holding AB, Babson College, and Indonesia International Institute For Life Sciences.
He is also a former Chief Executive Officer of Jönköping International Business School, Chairman of Ith Immune Therapy Holdings AB and TLA Targeted Immunotherapies AB, Director of TRUPOINT Partners, Inc., Independent Director of Karolinska Development AB, Executive Director of Stockholm School of Entrepreneurship, and President of IPMI Business School.
Postes actifs de Niclas Adler
| Sociétés | Poste | Début |
|---|---|---|
Indonesia International Institute For Life Sciences
 Indonesia International Institute For Life Sciences Other Consumer ServicesConsumer Services Indonesia International Institute for Life Sciences (i3l) is a premium life sciences higher education and research institute located in Jakarta, Indonesia. The institute offers ten undergraduate programs, including biomedicine, biotechnology, food science and nutrition, food technology, and pharmacy. The School of Life Sciences at i3l offers undergraduate programs in these fields. The Food Technology program aims to ensure safe manufacture, packaging, and distribution of food, while the Food Science and Nutrition program focuses on the role of food in maintaining future health. The Pharmacy program covers drug discovery, development, clinical trials, drug delivery, drug management, and patient counseling. The institute collaborates with other institutions, including the Business & Hotel Management School in Switzerland, to offer pathway programs. | President | - |
| PT Accelerated Value | Chairman | - |
| e-Cognition Pte Ltd. | Chairman | - |
| Accelerated Drug Development AB | Chairman | - |
| Babson College | Corporate Officer/Principal | - |
| SCI Innovation AB | Director/Board Member | - |
Ao Holding AB
 Ao Holding AB Miscellaneous Commercial ServicesCommercial Services Ao Holding AB engages in sociological and humanistic research and development. The private company is based in Sweden. | Director/Board Member | - |
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Chairman | - |
Anciens postes connus de Niclas Adler
| Sociétés | Poste | Fin |
|---|---|---|
| Jönköping International Business School | Chief Executive Officer | - |
| ░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░ ░░░░░░░░ ░░░░░░ | ░░░░░░░░░ | - |
| ░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| Entreprise privées | 10 |
|---|---|
TRUPOINT Partners, Inc.
 TRUPOINT Partners, Inc. Internet Software/ServicesTechnology Services TRUPOINT Partners, Inc. operates as regulatory compliance software and data analytics firm. Its solutions include compliance analytics software and consulting, regression analysis, branch Strategy and HMDA submission software. The company was founded in 2009 and is headquartered in Charlotte, NC. | Technology Services |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Health Technology |
| e-Cognition Pte Ltd. | |
Indonesia International Institute For Life Sciences
Indonesia International Institute For Life Sciences Other Consumer ServicesConsumer Services Indonesia International Institute for Life Sciences (i3l) is a premium life sciences higher education and research institute located in Jakarta, Indonesia. The institute offers ten undergraduate programs, including biomedicine, biotechnology, food science and nutrition, food technology, and pharmacy. The School of Life Sciences at i3l offers undergraduate programs in these fields. The Food Technology program aims to ensure safe manufacture, packaging, and distribution of food, while the Food Science and Nutrition program focuses on the role of food in maintaining future health. The Pharmacy program covers drug discovery, development, clinical trials, drug delivery, drug management, and patient counseling. The institute collaborates with other institutions, including the Business & Hotel Management School in Switzerland, to offer pathway programs. | Consumer Services |
| PT Accelerated Value | |
| Ith Immune Therapy Holdings AB | |
TLA Targeted Immunotherapies AB
 TLA Targeted Immunotherapies AB Electronic Equipment/InstrumentsElectronic Technology TLA Targeted Immunotherapies AB manufactures medical devices. The private company is based in Stockholm, Sweden. | Electronic Technology |
| Accelerated Drug Development AB | |
| SCI Innovation AB | |
Ao Holding AB
Ao Holding AB Miscellaneous Commercial ServicesCommercial Services Ao Holding AB engages in sociological and humanistic research and development. The private company is based in Sweden. | Commercial Services |
